These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 20051109)

  • 1. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.
    Valentine R; Dawson CW; Hu C; Shah KM; Owen TJ; Date KL; Maia SP; Shao J; Arrand JR; Young LS; O'Neil JD
    Mol Cancer; 2010 Jan; 9():1. PubMed ID: 20051109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.
    O'Neil JD; Owen TJ; Wood VHJ; Date KL; Valentine R; Chukwuma MB; Arrand JR; Dawson CW; Young LS
    J Gen Virol; 2008 Nov; 89(Pt 11):2833-2842. PubMed ID: 18931081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway.
    Xie Y; Li Y; Peng X; Henderson F; Deng L; Chen N
    Oral Oncol; 2013 Dec; 49(12):1113-20. PubMed ID: 24075781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.
    Cao JY; Mansouri S; Frappier L
    J Virol; 2012 Jan; 86(1):382-94. PubMed ID: 22013061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB Signaling Regulates Epstein-Barr Virus BamHI-Q-Driven EBNA1 Expression.
    Verhoeven RJA; Tong S; Zong J; Chen Y; Tsao SW; Pan J; Chen H
    Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29659505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
    Morrison TE; Kenney SC
    Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function.
    Duellman SJ; Thompson KL; Coon JJ; Burgess RR
    J Gen Virol; 2009 Sep; 90(Pt 9):2251-9. PubMed ID: 19439552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB-mediated transcriptional upregulation of TNFAIP2 by the Epstein-Barr virus oncoprotein, LMP1, promotes cell motility in nasopharyngeal carcinoma.
    Chen CC; Liu HP; Chao M; Liang Y; Tsang NM; Huang HY; Wu CC; Chang YS
    Oncogene; 2014 Jul; 33(28):3648-59. PubMed ID: 23975427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
    Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y
    Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.
    Port RJ; Pinheiro-Maia S; Hu C; Arrand JR; Wei W; Young LS; Dawson CW
    J Pathol; 2013 Nov; 231(3):367-77. PubMed ID: 23934731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
    Takada Y; Singh S; Aggarwal BB
    J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
    Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
    Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
    Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus tegument protein BGLF2 inhibits NF-κB activity by preventing p65 Ser536 phosphorylation.
    Chen T; Wang Y; Xu Z; Zou X; Wang P; Ou X; Li Y; Peng T; Chen D; Li M; Cai M
    FASEB J; 2019 Sep; 33(9):10563-10576. PubMed ID: 31337264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.